- Home
- BKD vs XNCR Comparison
BKD vs XNCR Comparison
Compare BKD & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKD
- XNCR
- Stock Information
- Founded
- BKD 2005
- XNCR 1997
- Country
- BKD United States
- XNCR United States
- Employees
- BKD N/A
- XNCR N/A
- Industry
- BKD Hospital/Nursing Management
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- BKD Health Care
- XNCR Health Care
- Exchange
- BKD Nasdaq
- XNCR Nasdaq
- Market Cap
- BKD 1.3B
- XNCR 1.3B
- IPO Year
- BKD 2005
- XNCR 2013
- Fundamental
- Price
- BKD $4.68
- XNCR $17.76
- Analyst Decision
- BKD Buy
- XNCR Strong Buy
- Analyst Count
- BKD 4
- XNCR 8
- Target Price
- BKD $7.50
- XNCR $34.63
- AVG Volume (30 Days)
- BKD 2.2M
- XNCR 534.5K
- Earning Date
- BKD 02-18-2025
- XNCR 02-25-2025
- Dividend Yield
- BKD N/A
- XNCR N/A
- EPS Growth
- BKD N/A
- XNCR N/A
- EPS
- BKD N/A
- XNCR N/A
- Revenue
- BKD $2,954,652,000.00
- XNCR $85,164,000.00
- Revenue This Year
- BKD $10.13
- XNCR N/A
- Revenue Next Year
- BKD $4.24
- XNCR $80.86
- P/E Ratio
- BKD N/A
- XNCR N/A
- Revenue Growth
- BKD 5.20
- XNCR N/A
- 52 Week Low
- BKD $4.51
- XNCR $15.31
- 52 Week High
- BKD $8.12
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- BKD 39.05
- XNCR 28.92
- Support Level
- BKD $4.51
- XNCR $19.15
- Resistance Level
- BKD $4.85
- XNCR $19.45
- Average True Range (ATR)
- BKD 0.17
- XNCR 0.97
- MACD
- BKD -0.01
- XNCR -0.15
- Stochastic Oscillator
- BKD 28.33
- XNCR 11.60
About BKD Brookdale Senior Living Inc.
Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments; Independent Living; Assisted Living and Memory Care; and Continuing Care Retirement Communities (CCRs). Majority of the revenue is generated from the Assisted Living and Memory Care segment that offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees which it receives in exchange for the services provided, and in the form of management fee from certain communities under contract, in exchange for the management services provided.
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.